Mouse Genome Engineering Core Facility
小鼠基因组工程核心设施
基本信息
- 批准号:9338261
- 负责人:
- 金额:$ 4.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Animal ModelBiomedical ResearchClientComplexConsultationsCore FacilityDevelopmentDevelopmental ProcessDiseaseEmbryoEmbryo TransferEquipmentFacultyFemaleFundingFutureGenerationsGeneticGenetic EngineeringGenetically Engineered MouseGenome engineeringGenotypeGoalsHuman ResourcesIndividualInjection of therapeutic agentInstitutesInvestigationInvestmentsKnockout MiceLaboratoriesLearningMedical centerMethodsMicroinjectionsMicromanipulationMolecular BiologyMouse StrainsMusNatureNebraskaNobel PrizeOperative Surgical ProceduresPhaseProceduresRecombinantsResearchResearch InfrastructureResearch PersonnelResourcesServicesSpeedStudentsSystemTechniquesTechnologyTimeTrainingTraining and EducationTransgenesTransgenic MiceTransgenic OrganismsUnited States National Institutes of HealthUniversitiesbaseblastocystcongeniccost effectivedesignembryonic stem cellgenome editingimprovedinnovationinterestmembermodel designmouse genomemouse modelneurosensorynew technologypregnantskillssuccesstraining opportunitytranscription activator-like effector nucleasesvector
项目摘要
As one of the important scientific cores of the Center for the Molecular Biology of Neurosensory Systems,
the goals of Mouse Genome Engineering Core facility (MGECF) are i) to serve all the needs of CoBRE
investigators related to the design and creation of transgenic and knockout mouse models, ii) undertake
technological research to continuously Improve genetic engineering methods and iii) to provide education
and training opportunities to students, researchers and faculty. MGECF was supported by CoBRE during its
Phase I at which time the facility was in the initial stages of development. By the end of Phase I the facility
was fully functional in creating the mouse models by employing standard mouse embryo manipulation
techniques such as microinjection and transferring into pseudo-pregnant females. During the CoBRE phase
II period the facility has achieved significant accomplishments: i) started offering critical services such as the
design and building of transgenic and targeting vectors that were done previously by the investigators; ii)
initiated many other services such as mouse genotyping and speed congenics; iii) acquired additional
equipment and personnel and provided training to enhance their overall skills (both scientific and
administrative); and iv) initiated research on the most advanced genome engineering methods to validate
them for offering as new services. Notably, the MGECF is among the first three such core facilities in the
nation that started offering'the genome editing service TALENs (Transcription Activator Like Effector
Nucleases). The core almost tripled its user base in 2010 and has maintained it at that level since then. It
has has successfully increased its revenue in the recent three years, becoming less dependent of CoBRE
support and demonstrating its capability to become sustainable in the future. This core facility is one of the
most critical core facilities in the region that serves many investigators across three different institutes.
Because of necessity as well as its remarkable success, the MGECF is supported by the UNMC office of the
Vice Chancellor for Research. Additionally, the VCR office has a strong commitment to provide support
beyond Phase III of CoBRE support.
作为神经感觉系统分子生物学中心的重要科学核心之一,
小鼠基因组工程核心设施 (MGECF) 的目标是 i) 满足 CoBRE 的所有需求
与转基因和基因敲除小鼠模型的设计和创建相关的研究人员,ii) 承担
技术研究不断改进基因工程方法和 iii) 提供教育
为学生、研究人员和教师提供培训机会。 MGECF 在其成立期间得到了 CoBRE 的支持
第一阶段,该设施处于开发的初始阶段。到第一阶段结束时,该设施
通过采用标准小鼠胚胎操作来创建小鼠模型,功能齐全
显微注射和移植到假怀孕女性体内等技术。在 CoBRE 阶段
第二阶段该设施取得了重大成就:i) 开始提供关键服务,例如
研究人员之前完成的转基因和靶向载体的设计和构建;二)
启动了许多其他服务,例如小鼠基因分型和速度同类; iii) 获得额外的
设备和人员,并提供培训以提高他们的整体技能(科学和技能)
行政); iv) 启动了最先进的基因组工程方法的研究以验证
他们提供新服务。值得注意的是,MGECF 是该国首批三个此类核心设施之一。
开始提供基因组编辑服务 TALEN(转录激活因子样效应器)的国家
核酸酶)。 2010 年,该核心的用户基数几乎增加了两倍,此后一直保持在这一水平。它
近三年来成功增加了收入,减少了对 CoBRE 的依赖
支持并展示其未来可持续发展的能力。该核心设施是其中之一
该地区最重要的核心设施为三个不同研究所的许多研究人员提供服务。
由于必要性以及其显着的成功,MGECF 得到了 UNMC 办公室的支持
研究副校长。此外,VCR 办公室坚定致力于提供支持
超出 CoBRE 支持的第三阶段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Channabasavaiah Gurumurthy其他文献
Channabasavaiah Gurumurthy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Channabasavaiah Gurumurthy', 18)}}的其他基金
Development of humanized transgenic mice for HBV/HIV co-infection studies
开发用于 HBV/HIV 共感染研究的人源化转基因小鼠
- 批准号:
9882941 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
10202690 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
10666490 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
9815153 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
Development of Modular CRISPR Genome Editing Technologies and Tools
模块化CRISPR基因组编辑技术和工具的开发
- 批准号:
10448385 - 财政年份:2019
- 资助金额:
$ 4.2万 - 项目类别:
相似国自然基金
面向生物医学文本的知识自动总结研究
- 批准号:72304189
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生物医学跨本体术语相似度方法及其在B细胞非霍奇金淋巴瘤中的应用研究
- 批准号:62372276
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
面向生物医学领域的多模态学术图像不端检测技术研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
水凝胶光纤氧气传感关键问题研究及在生物医学中的应用
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
金属配位诱导的靶向蛋白降解平台的构建及生物医学应用研究
- 批准号:22277141
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
相似海外基金
CSHL 2022 Protein Homeostasis in Health and Disease Conference
CSHL 2022健康与疾病中的蛋白质稳态会议
- 批准号:
10452207 - 财政年份:2022
- 资助金额:
$ 4.2万 - 项目类别:
Large Animal Facility for Imaging and Image-guided Therapies at MSU
密歇根州立大学用于成像和图像引导治疗的大型动物设施
- 批准号:
10373769 - 财政年份:2021
- 资助金额:
$ 4.2万 - 项目类别: